Results 11 to 20 of about 636,200 (242)

Baseline ECG and Prognosis After Transcatheter Aortic Valve Implantation: The Role of Interatrial Block [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background The clinical significance of conduction disturbances after transcatheter aortic valve implantation has been described; however, little is known about the influence of baseline ECGs in the prognosis of these patients.
Lourdes Vicent, Clara Fernández‐Cordón, Luis Nombela‐Franco, Luis Alberto Escobar‐Robledo, Ana Ayesta, Albert Ariza Solé, Juan José Gómez‐Doblas, Eva Bernal, Gabriela Tirado‐Conte, Javier Cobiella, Hugo González‐Saldivar, Diego López‐Otero, Pablo Díez‐Villanueva, Fernando Sarnago, Xavier Armario, Antonio Bayés‐de-Luna, Manuel Martínez‐Sellés   +16 more
doaj   +2 more sources

Transcatheter aortic valve implantation: the procedure

Heart, 2012
Transcatheter aortic valve implantation (TAVI) for the treatment of symptomatic severe aortic stenosis has emerged as an effective treatment for high risk patients. In 2002 TAVI was performed for the first time in a human by Alain Cribier, using an antegrade access approach via the femoral vein, crossing the intra-atrial septum after puncture and ...
Stortecky Stefan, Buellesfeld Lutz, Wenaweser Peter, Windecker Stephan   +3 more
openaire   +5 more sources

Transcatheter Aortic Valve Implantation [PDF]

Global Cardiology Science and Practice, 2012
Transcatheter aortic valve implantation was first described by Cribier in 2002 [1] and since then has evolved as a routine procedure for high-risk patients with aortic stenosis [2, 3]. As by June 2010, 10,000 transfemoral (TF) implants of the CoreValve™ prosthesis (Medtronic Inc., Minneapolis, MN, USA) and approximately a similar number of TF and ...
Falk, Volkmar, Walther, Thomas
  +9 more sources

Transcatheter aortic valve implantation [PDF]

F1000Prime Reports, 2014
Transcatheter aortic valve implantation was developed to offer a therapeutic solution to patients with severe symptomatic aortic stenosis who are not candidates for conventional aortic valve replacement. The improvement in transcatheter aortic valve implantation outcomes is still of concern in the areas of stroke, vascular injury, heart block ...
Oliemy, Ahmed, Al-Attar, Nawwar
openaire   +4 more sources

Transcatheter Aortic Valve Implantation [PDF]

Journal of the American College of Cardiology, 2011
Transcatheter aortic valve implantation (TAVI) was first introduced by Alan Cribier in 2002.1 Since their introduction, the two available devices (the Cribier-Edwards aortic valve [Edwards Lifesciences] and the CoreValve [Medtronic]) have decreased in size and are more flexible, improving deliverability.
Vahanian, Alec, Himbert, Dominique, Iung, Bernard   +2 more
openaire   +3 more sources

Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation

The American Journal of Cardiology, 2022
The use of valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is increasing, but studies evaluating clinical outcomes in these patients are scarce. Also, there are limited data to guide the choice of valve type in ViV-TAVI. Therefore, this CENTER-study evaluated clinical outcomes in patients with ViV-TAVI compared to patients with native
Astrid C. van Nieuwkerk, Raquel B. Santos, Eduard Fernandez-Nofrerias, Didier Tchétché, Fabio S. de Brito, Marco Barbanti, Ran Kornowski, Azeem Latib, Augusto D'Onofrio, Flavio Ribichini, Vicente Mainar, Nicolas Dumonteil, Jan Baan, Alexandre Abizaid, Samantha Sartori, Paola D'Errigo, Giuseppe Tarantini, Mattia Lunardi, Katia Orvin, Matteo Pagnesi, Garikoitz Lasa Larraya, Angie Ghattas, George Dangas, Roxana Mehran, Ronak Delewi   +24 more
openaire   +6 more sources

Direct aortic transcatheter aortic valve implantation

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2021
Transcatheter aortic valve implantation (TAVI) is a safe and effective alternative to surgical valve replacement in intermediate and even in low-risk patient cohorts. Direct aortic (DAo) route may be used in patients with severe peripheral vascular disease. Here, we present an 88-year old patient hospitalized with cardiogenic shock.
Emir Karaçağlar, Arzu Neslihan Akgün, Alp Aydınalp, Deniz Sarp Beyazpınar, Atila Sezgin, Haldun Müderrisoğlu   +5 more
openaire   +3 more sources

Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)- systematic review and meta-analysis [PDF]

, 2014
The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading ...
Webb, J, Reinthaler, M, Georg M Fröhlich, Marco Roffi, Olaf Wendler, Nevil Hutchinson, Markus Reinthaler, Duolao Wang, David Hildick-Smith, Wang, D, Hutchinson, N, Fröhlich, GM, John Webb, Pascal Meier, Alexandra J Lansky, Wendler, O, Hildick-Smith, D, Stefan Toggweiler, Lansky, AJ, Roffi, M, Meier, P, Toggweiler, S, Roffi, Marco, Wendler, Olaf, Webb, John, Lansky, Alexandra J, Wang, Duolao, Meier, Pascal, Hildick-Smith, David, Hutchinson, Nevil, Toggweiler, Stefan, Fröhlich, Georg M, Reinthaler, Markus   +32 more
core   +2 more sources

Imaging of Bioprosthetic Valve Dysfunction after Transcatheter Aortic Valve Implantation. [PDF]

, 2023
Transcatheter aortic valve implantation (TAVI) has become the standard of care in elderly high-risk patients with symptomatic severe aortic stenosis. Recently, TAVI has been increasingly performed in younger-, intermediate- and lower-risk populations ...
Brugger, Nicolas, Windecker, Stephan, Benedikt Bernhard, Thomas Pilgrim, Stefano F. de Marchi, Christoph Gräni, De Marchi, Stefano F, Fabien Praz, Louhai Alwan, Nicolas Brugger, Alwan, Louhai, Praz, Fabien Daniel, Stephan Windecker, Bernhard, Benedikt, Pilgrim, Thomas, Gräni, Christoph   +15 more
core   +2 more sources

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source